Gland Pharma's consolidated profit after tax for Q3 FY25 increased by 7% to Rs 205 crore, while revenue declined to Rs 1,384 crore.

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

India's benchmark indices, Sensex and Nifty, ended flat following Finance Minister Nirmala Sitharaman's Union Budget 2025 ...

From the 30-share blue-chip pack, Zomato surged over 7 per cent. Maruti, ITC Hotels, ITC, Mahindra & Mahindra, Asian Paints, Titan and IndusInd Bank were among the biggest gainers. Power Grid, Larsen ...

By Hritam Mukherjee (Reuters) -Indian infrastructure stocks declined in a special trading session on Saturday, with sector ...

By Hritam Mukherjee (Reuters) -Indian infrastructure and cement stocks declined in a special trading session on Saturday, as ...